1Kin WS,Song SY,Ahn YC,et al.CHOP followed by involved field radiation:is it optimal for localized nasal natural killer/T-cell lymphoma[J].Ann Oncol,2001(12):349-352.
3Liang R,Todd D,Chan TK,et al.Treatment outcome and prognostic factors for primary nasal lymphoma[J].J Clin Oncol,1995(13):666-670.
4Harris NL,Jaffe ES,Stein H,et al.A revised European-American classification of lymphoid neoplasms:a proposal from the International Lymphoma Study Group[J].Blood,1994(84):1361-1392.
5Jaffe ES,Harris NL,Diebold J,et al.World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues:a progress report[J].Am J Clin Pathol,1999,111.
7Li YX,Coucke PA,Li JY,et al.Primary non-Hodgkin's lymphoma of the nasal cavity:prognostic significance of paranasal extension and the role of radiotherapy and chemotherpy[J].Cancer,1998(83):449-456.
8Kinby E,Brandt L,Nygren P,et al.A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoma[J].Acta Oncologica,2001(40):198-212.
9Li T,Hongyo T,Syaifudin M,et al.Mutations of the p53 gene in nasal NK/T-cell lymphoma[J].Lab Invest,2000(80):493-499.
